preliminary investigation pseudomonas aeruginosa vaccine patient leukemia cystic fibrosis heptavalent lipopolysaccharide vaccine pseudomonas developed clinical trial revealed decreased incidence sepsis mortality due pseudomonas vaccinated patient burn vaccinated certain group immunosuppressed patient cancer may also decreased incidence death associated pseudomonas trial parenteral vaccination patient cystic fibrosis show little benefit adverse reaction vaccine frequent often limit dose given